DeviceTalks Boston Preview Episode – Four of the Many Amazing Voi...

Why It Matters

Device Talks Boston spotlights how AI and large‑scale neuro‑device trials are reshaping med‑tech financing and patient care, offering investors and innovators a roadmap to accelerate brain‑health solutions.

Key Takeaways

• Device Talks Boston scheduled May 27‑28 at BCE, 25% discount code.
• Cognto Therapeutics raised $13M, showcasing AI‑enhanced fundraising success.
• Cognto’s Spectrris device leads largest non‑pharma Alzheimer trial.
• AI tools refined investor pitch narratives and clinical storytelling.
• New collaborations with Rockefeller and Ashner expand brain‑health applications.

Summary

The episode serves as a preview for Device Talks Boston, a two‑day med‑tech conference on May 27‑28 at the Boston Convention & Exhibition Center. Host Tom Salmi urges listeners to register using code DTW25 for a 25 % discount and highlights the event’s mix of startup founders, investors, and corporate innovators.

Key announcements include Cognto Therapeutics CEO Christian Howell discussing the company’s $13 million raise and its AI‑driven fundraising workflow. Cognto will showcase its Spectrris non‑invasive 40 Hz gamma‑wave device, now in a 673‑patient, 12‑month sham‑controlled Alzheimer’s study—the largest of its kind.

Howell explains that MIT researchers discovered 40 Hz stimulation can preserve brain volume and cognition, and Cognto’s feasibility data showed 77 % functional preservation versus sham. He also described using a GPT‑based note‑taking system to refine investor pitches, underscoring AI’s role in narrative building.

The conference promises deep dives into AI‑enabled startup management, clinical validation, and new collaborations with the Rockefeller Neuroscience Institute and Ashner Health, signaling broader applications beyond Alzheimer’s. Attendees will gain insights into scaling med‑tech ventures, regulatory pathways, and cost‑saving models for health systems.

Original Description

In this special DeviceTalks Weekly Podcast episode, Host Tom Salemi previews the biggest conversations, technologies, and innovators heading to DeviceTalks Boston on May 27–28 at the Boston Convention & Exhibition Center.

First, Tom Salemi and Mike Moore, partner at The Mullings Group, visits with Christian Howell, CEO of Cognito Therapeutics. Howell will be speaking at DeviceTalks Boston about the neuro company’s clinical, fund-raising and partnering success.

Howell also shares insights into Cognito’s partnerships with research institutions and the future of noninvasive therapies for neurodegenerative disease. He’ll be among the many speakers address Innovation & Investment at the conference, with others including the MedTech Innovator Open Rounds sessions and venture capital investors including Abby Hunter-Syed of Olympus Innovation Ventures and Maria Berkman, MD, of Vensana Capital.

Tom and Holly Scott also speak with Dr. Sarah Matt, author of Borderless Healthcare Revolution, about the challenges of connected health adoption and why many health-tech pilots fail to scale. Matt previews her DeviceTalks Boston panel examining the “physician veto” and the barriers device makers face when introducing new digital health technologies into clinical environments.

Several sessions at DeviceTalks Boston will address the challenges and opportunities of Connected Health including a keynote interview with Ashley McEvoy, CEO of Insulet, as well as presentations by Philips, Baxter and others.

The episode also features a wide-ranging conversation with Mullings Group leaders Mike Moore and Holly Scott about the strength of the Massachusetts medtech ecosystem, the growth of surgical robotics, and the importance of conferences in building meaningful industry relationships.

If you want to join us at DeviceTalks Boston, you can register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the price of registration.

***

Enjoy the show? Follow [DeviceTalks Weekly](https://devicetalksweekly.castos.com/subscribe) on all major podcast players + Follow us on [YouTube.com/@DeviceTalks](https://www.youtube.com/@DeviceTalks) to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

00:03:40 Mike Moore of The Mulling Group and Tom interview Christian Howell, CEO of Cognito Therapeutics

00:15:40 Holly Scott of the Mullings Group and Tom interview Sarah Matt, MD, author of The Borderless Healthcare Revolution

00:22:30 Holly, Mike and Tom breakdown the components of DeviceTalks Boston and the Massachusetts MedTech industry